Sanofi’s Venglustat Scores Phase 3 Win in Neurological Gaucher Disease, Stumbles in Fabry Trial
February 4, 2026 | by Aditya Mohapatra
Reading Time: 2 minutesSanofi’s investigational rare disease drug venglustat delivered a Phase 3 win in neurological Gaucher disease but failed in a separate […]
Read More →
Top Stories
February 4, 2026
Aditya Mohapatra
No News Available
latest news
Sanofi’s investigational...
No posts found
Get The Free Newsletter
Subscribe to BiomedToday for top news, trends & analysis
Most Read
BIOMED EXCLUSIVES
research
2 months ago
2 months ago
3 months ago
5 months ago
5 months ago
No posts found
biotech
3 months ago
3 months ago
5 months ago
No posts found
fda
2 months ago
2 months ago
2 months ago
4 months ago
7 months ago
No posts found
clinical trials
2 months ago
4 months ago
5 months ago
7 months ago
No posts found
trending
No News Available
No News Available